Early Access

10-QPeriod: Q3 FY2021

ECOLAB INC. Quarterly Report for Q3 Ended Sep 30, 2021

Filed October 29, 2021For Securities:ECL

Summary

Ecolab Inc. (ECL) reported strong financial results for the third quarter and first nine months of 2021, demonstrating robust recovery and growth. Net sales increased by 10% to $3.32 billion for the quarter and 7% to $9.37 billion for the nine-month period compared to the prior year. This growth was driven by volume increases, pricing adjustments, and a recovery in market conditions across key segments, particularly Global Industrial and Global Institutional & Specialty. Profitability also saw significant improvement, with operating income rising 13% to $466 million for the quarter and 24% to $1.21 billion for the nine months. Net income from continuing operations attributable to Ecolab surged by 32% to $324 million in the third quarter, and by 24% to $829 million for the nine-month period. Diluted EPS from continuing operations also showed strong growth, reaching $1.12 for the quarter and $2.87 for the nine months. The company managed inflationary pressures on product costs through effective pricing strategies and operational efficiencies. Looking ahead, Ecolab announced a significant subsequent event: an agreement to acquire Purolite Corporation for $3.7 billion, which is expected to further enhance its offerings in life sciences and critical industrial markets.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased by 10% to $3.32 billion in Q3 2021 and by 7% to $9.37 billion for the first nine months of 2021, compared to the prior year.
  • 2Operating income grew by 13% to $465.8 million in Q3 2021 and by 24% to $1.21 billion for the nine-month period.
  • 3Net income from continuing operations attributable to Ecolab increased by 32% to $324.5 million in Q3 2021 and by 24% to $828.9 million for the nine-month period.
  • 4Diluted EPS from continuing operations was $1.12 in Q3 2021, a 32% increase, and $2.87 for the nine-month period, a 25% increase.
  • 5The company experienced strong recovery in its Global Industrial (up 7% fixed currency sales) and Global Institutional & Specialty (up 18% fixed currency sales) segments.
  • 6Despite inflationary pressures on delivered product costs, adjusted gross margin remained robust, supported by pricing and volume leverage.
  • 7Ecolab announced a subsequent event: an agreement to acquire Purolite Corporation for $3.7 billion, enhancing its life sciences and industrial purification solutions.

Frequently Asked Questions